Given the patient's multiple comorbidities and risk of drug interactions, we recommend a comprehensive bleeding risk assessment before initiating anticoagulation therapy. 鉴于患者存在多重合并症和药物相互作用风险,我们建议在开始抗凝治疗前进行全面的出血风险评估。